News

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}
Welcome to our Corporate client solution

Here you can administrate your corporate solutions users.
Welcome to your subscription for Life Science Focus
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Focus.

Click here to go to sign-up

Advertisement

Advertisement

AstraZeneca unveils major cost-cutting drive

People & Careers

Sobi proposes Börje Ekholm as new chair

SynAct Pharma signs first dengue drug deal

Lilly’s triple-G drug outperforms Ozempic in head-to-head trial

Ferring to buy IVF biotech in billion-dollar deal

Advertisement

Danish drug candidate shows great response to two cancer types

Cell therapy scrapped after patient deaths in trial — 94 per cent of staff laid off

Medtech

Abbott sharpens cancer test – detects smaller traces of tumour DNA

In Focus

How GLP-1 drugs are changing what we buy at the supermarket

Sponsored content News from our members

SGS Fimko

Structured Dialogue with SGS Fimko – a clearer path through MDR and IVDR

GRUBER A/S

GRUBER aims to eliminate bottlenecks in pharmaceutical production

Aurevia

What if some of the most influential systems in healthcare are the least regulated?

Aurevia

From regulatory requirements to clinical reality: putting clinical & performance evidence into focus

GBA Key2Compliance AB

AI in Medical Devices: Understanding the Review Process and Common Gaps

Aurevia

Upcoming Course: Quality Management System according to EN ISO 13485:2016 - in practice

GRUBER A/S

Let's connect at COMPAMED 2026 in Düsseldorf

OEM Automatic AB

Effektiv flödesmätning för vatten- och avloppssystem med FLUXUS WD

OEM Automatic AB

Smartare kvalitetskontroll med Zebra NS42 från OEM Automatic

Aurevia

QAdvis & Scandinavian CRO are now Aurevia

KNF Neuberger AB

Pumphuvudkonfiguration: Optimera flöde och vakuumprestanda

Aurevia

From innovation to compliance: Medtech Compliance Forum by Aurevia & RAPS explores health technology

See all announcements

Column

Björn Ursing: “What happens when trust in science erodes?”

Advertisement

Danish heart drug developer heads for Swedish stock market

People & Careers

AlzeCure CEO steps down – co-founder takes over

Interview

Study finds key gut bacterium undetectable in one in three Swedish infants

Advertisement

AstraZeneca considers move into cancer vaccines

Xbrane wins long-awaited FDA approval for eye drug biosimilar

Advertisement

Sponsored content

”Cybersecurity Is Patient Safety”

Advertisement

Advertisement

Interview

Denmark a leader in EU clinical trials: “We should never accept unnecessary delays”

New lung cancer combo shown to extend survival by eight months

Interview

Early gene therapy offers hope for some ALS patients

Advertisement

Enhertu wins EU approval in early breast cancer

J&J hails early prostate cancer data as “the best we have ever seen”

Medtech

Miris under pressure as sales fall – CEO steps down

Advertisement

Roche scores phase III win with lung cancer drug

Advertisement

Yes please, I would like to receive Life Science Focuss newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Focus Read cookie and data policy.

Advertisement Advertisement

BREAKING

{{ article.headline }}

0.062|instance-web03